Matthew Osman
About Matthew Osman
Matthew Osman is a co-founder of Treat, where he has worked since 2021, focusing on AI technologies aimed at enhancing cognitive function and preventing neurodegenerative diseases. He has a background in finance and a strong interest in the intersection of technology and neuroscience, and he co-founded the Longevity Biotech Fellowship to promote collaboration in longevity biotechnology.
Work at Treat AI
Matthew Osman serves as Co-Founder at Treat AI, a position he has held since 2021. Based in New York, he has contributed to the company's mission of enhancing cognitive function and preventing neurodegenerative diseases through innovative AI solutions. His role involves strategic oversight and direction in the development of technologies aimed at improving brain health.
Education and Expertise
Matthew Osman has a diverse educational background. He studied at Eton College and later attended the University of Oxford, where he earned a Bachelor of Arts (B.A.) in Philosophy, Politics, and Economics. He also obtained a Postgraduate Diploma in Bar Professional Training from City, University of London. Additionally, he studied at the CFA Institute, further enhancing his expertise in finance and investment.
Background in AI and Neuroscience
Matthew Osman has founded three AI companies focused on enhancing cognitive function and preventing neurodegenerative diseases. His strong interest lies at the intersection of technology and neuroscience, particularly in relation to longevity and brain health. This focus has guided his career choices and initiatives in the biotechnology sector.
Leadership Roles and Initiatives
Matthew Osman has held various leadership roles throughout his career. He was the CEO and Co-Founder of Legit from 2016 to 2020 in Cambridge, Massachusetts, and served as Vice President of Strategy at Clora for seven months in 2020. He co-founded the Longevity Biotech Fellowship in 2023, a non-profit community aimed at fostering collaboration among investors, scientists, and entrepreneurs in the field of longevity biotechnology.
Previous Experience in Finance
Before entering the technology and biotechnology sectors, Matthew Osman worked at Pearl Diver Capital as part of the Credit Team from 2015 to 2016 in London, United Kingdom. This experience provided him with a solid foundation in finance, which he has applied in his subsequent ventures.